stocksMOLBIO
1,259.70-62.9 (-4.76%)
22 Oct, 12:00 AM

Annual Reports and Financial Documents

Molbio Diagnostics Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
2026
Annual Reports—
Quarterly Results—
Conference Calls
Presentations

Corporate Announcements and Regulatory Filings

Molbio Diagnostics Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. General19 Oct 2026
    Clarification On Spurt In Volume Of Shares Of The Company.
    Clarification on Spurt in Volume of shares of the Company.
  2. Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 201116 Oct 2026
    Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Kotak Mahindra Mutual Fund
  3. Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 201113 Oct 2026
    Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Kotak Mahindra Mutual Fund
  4. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20188 Oct 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Certificate under Regulation 74(5) of the SEBI(Depositories and Participants)Regulations, 2018 for the quarter ended September 30,2026.
  5. Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 20111 Oct 2026
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for India Business Excellence Fund III
  6. Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 20111 Oct 2026
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for India Business Excellence Fund III,
  7. Closure of Trading Window28 Sept 2026
    Closure of Trading Window
    Intimation of Closure of Trading Window for the Quarter ended September 30,2026.
  8. Outcome without intimation25 Sept 2026
    Board Meeting Outcome for Re-Appointment Of Cost Auditor Of The Company For FY 2026-27.
    Intimation of re-appointment of Cost Auditor of the Company pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015.
  9. Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201125 Sept 2026
    Revised Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for India Business Excellence Fund III
  10. Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201125 Sept 2026
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for India Business Excellence Fund III
  11. Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201124 Sept 2026
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for India Business Excellence Fund III
  12. Analyst / Investor Meet17 Sept 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation of Analysts/Investors Meeting under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, scheduled to be held on Tuesday, September ....
  13. General9 Sept 2026
    Change Of Corporate Identification Number (CIN) Of The Company.
    Intimation of Change of Corporate Identification Number (CIN) of the company.
  14. Analyst / Investor Meet8 Sept 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    Audio Recording of Earnings Call for the quarter ended June 30, 2026.
  15. Newspaper Publication7 Sept 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper advertisments of Un-Audited Financials Results for the quarter ended June 30, 2026.
  16. Press Release / Media Release7 Sept 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Molbio Diagnostics Limited has informed the Exchange regarding the Press Release for the Quarter ended June 30,2026.
  17. Outcome of Board Meeting5 Sept 2026
    Board Meeting Outcome for Outcome Of Board Meeting.
    The Board of Directors at their meeting held on Saturday, September 05, 2026 approved the Un-audited Financial Results (Standalone & Consolidated) for the quarter ended on June 30, 2026
  18. Analyst / Investor Meet2 Sept 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation of Earnings Conference Call under Regulation 30 and all other applicable regulations, if any, of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) ....
  19. Board Meeting1 Sept 2026
    Board Meeting Intimation for To Consider And Approve The Financial Results For The Quarter Ended 30 June 2026.
    Molbio Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/09/2026 ,inter alia, to consider and approve To consider and approve ....
  20. Outcome without intimation27 Aug 2026
    Board Meeting Outcome for Outcome Of Board Meeting Held On August 27, 2026, As Per Reg 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations').
    Outcome of Board Meeting held on August 27, 2026, as per Reg 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations').

Frequently Asked Questions

Where can I download the annual report of Molbio Diagnostics Ltd.?
Annual reports of Molbio Diagnostics Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Molbio Diagnostics Ltd.?
Quarterly earnings results and presentations of Molbio Diagnostics Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Molbio Diagnostics Ltd. publish earnings call transcripts?
Earnings call transcripts of Molbio Diagnostics Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Molbio Diagnostics Ltd.?
Investor presentations and annual day presentations of Molbio Diagnostics Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Molbio Diagnostics Ltd.?
Corporate announcements and regulatory filings of Molbio Diagnostics Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Molbio Diagnostics Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Molbio Diagnostics Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Molbio Diagnostics Ltd.?
The ISIN (International Securities Identification Number) of Molbio Diagnostics Ltd. is INE869T01028. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Molbio Diagnostics Ltd. listed?
Molbio Diagnostics Ltd. is listed on NSE and BSE. The NSE symbol is MOLBIO and the BSE code is -.
Where can I find the shareholding pattern of Molbio Diagnostics Ltd.?
The quarterly shareholding pattern of Molbio Diagnostics Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Molbio Diagnostics Ltd. on Sharpely?
Share price data for Molbio Diagnostics Ltd. is updated as of 22 Oct 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.